secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001104659-24-095236
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA Pharma: two directors resign; Julie O'Neill appointed Non-Executive Chair
--------------------------------------------------------------------------------

- Jan van de Winkel and Tim Reilly resign effective Aug 30, 2024, citing increased time commitments from other roles.
- Julie O'Neill appointed Non-Executive Chair; Board reduced from 6 to 5 members.
- Board reclassified into three classes; O'Neill reappointed as Class I director, term expiring at 2026 Annual Meeting.
- Audit Committee: Cassidy (Chair), Kaufman, O'Neill; Compensation: O'Neill (Chair), Cassidy; Nominating: Kaufman (Chair), Cassidy.
- Resignations not due to any disagreement with Company's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/tm2423083d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-095236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer